Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 8698192)

Published in Gastroenterology on July 01, 1996

Authors

A J Sanyal1, A M Freedman, V A Luketic, P P Purdum, M L Shiffman, J Tisnado, P E Cole

Author Affiliations

1: Division of Gastroenterology, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

Articles citing this

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33

TIPSS 10 years on. Gut (2000) 1.48

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20

Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol (2013) 1.05

Modern management of oesophageal varices. Postgrad Med J (2001) 1.03

Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03

The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol (2012) 1.00

Bleeding gastric varices: results of endoscopic injection with cyanoacrylate at King Chulalongkorn Memorial Hospital. World J Gastroenterol (2005) 0.98

Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93

Management of portal hypertension. Postgrad Med J (2004) 0.90

Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve. Ann Surg (2003) 0.89

Long-term results with the modified Sugiura procedure for the management of variceal bleeding: standing the test of time in the treatment of bleeding esophageal varices. World J Surg (2012) 0.87

The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86

Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86

Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol (2011) 0.85

Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol (2016) 0.84

Variceal bleeding from ileum identified and treated by single balloon enteroscopy. World J Gastroenterol (2009) 0.83

Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol (2009) 0.83

Endoscopic Diagnosis and Therapy in Gastroesophageal Variceal Bleeding. Gastrointest Endosc Clin N Am (2015) 0.81

Acute variceal bleeding: general management. World J Gastroenterol (2001) 0.81

Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci (1998) 0.80

Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices - recommendations of the Working Group of the National Consultant for Gastroenterology. Prz Gastroenterol (2014) 0.80

Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol (2005) 0.80

Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol (2014) 0.79

When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Langenbecks Arch Surg (2003) 0.78

Current status of transjugular intrahepatic portosystemic shunts. Postgrad Med J (1998) 0.78

Gastrointestinal endoscopy in pregnancy. World J Gastroenterol (2014) 0.78

Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. World J Gastroenterol (2014) 0.77

Direct intrahepatic portacaval shunt: an experimental study. World J Gastroenterol (2003) 0.77

Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75

Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. Ann Gastroenterol (2013) 0.75

Potential Pitfalls in Transjugular Portosystemic Shunt Placement for Bleeding Rectal Varices. Case Rep Gastroenterol (2015) 0.75

Articles by these authors

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology (2001) 8.09

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74

The molecular mechanism of thermal unfolding of Escherichia coli formylmethionine transfer RNA. J Mol Biol (1974) 3.25

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology (2001) 3.02

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology (1994) 2.81

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA (1997) 2.80

Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.69

Right lobe living donor liver transplantation. Transplantation (1999) 2.31

Conformational changes of transfer ribonucleic acid. Equilibrium phase diagrams. Biochemistry (1972) 2.27

Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology (1998) 2.20

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology (1999) 2.11

Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine. Med Phys (1999) 1.82

The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology (1997) 1.74

Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics (1993) 1.68

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67

Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation (1997) 1.67

Clinical antidepressant activity of cyclazocine--a narcotic antagonist. Clin Pharmacol Ther (1970) 1.62

Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation (2000) 1.57

Splanchnic artery aneurysms and pseudoaneurysms: transcatheter embolization. Radiology (1987) 1.55

The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology (1996) 1.55

Evolution in vitro: sequence and phenotype of a mutant RNA resistant to ethidium bromide. J Mol Biol (1974) 1.51

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 1.49

Society of Cardiovascular & Interventional Radiology position statement on radiation safety. J Vasc Interv Radiol (2001) 1.48

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl (2001) 1.45

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. Aliment Pharmacol Ther (2004) 1.45

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation (2000) 1.42

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther (2015) 1.41

Lymphoscintigraphy as a guide to treatment in malignant melanoma. Ann Plast Surg (1989) 1.38

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology (1994) 1.35

A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg (1995) 1.33

Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation (2000) 1.25

Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol (2001) 1.22

Conformational changes of transfer ribonucleic acid. Relaxation kinetics of the early melting transition of methionine transfer ribonucleic acid (Escherichia coli). Biochemistry (1972) 1.20

Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. Hepatology (1997) 1.18

Level of education, level of income, and level of fatness in adults. Am J Clin Nutr (1977) 1.09

Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun (2012) 1.08

Metformin-induced acute hepatitis. Am J Med (1998) 1.01

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation (1998) 1.00

Studies of EN-1639A (naltrexone): a new narcotic antagonist. Am J Psychiatry (1974) 0.98

Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol (1999) 0.97

Naloxone in heroin dependence. Clin Pharmacol Ther (1968) 0.97

Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation (2000) 0.96

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study. Radiology (2000) 0.95

Modification of cytidines in a Q beta replicase template: analysis of conformation and localization of lethal nucleotide substitutions. Biochemistry (1980) 0.94

Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant (2003) 0.94

Drug addiction: an eclectic view. JAMA (1966) 0.93

Recurrent carcinoma of the cervix: CT diagnosis. AJR Am J Roentgenol (1981) 0.93

Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol (1999) 0.93

Sex discriminatory effectiveness using combinations of root lengths and crown diameters. Am J Phys Anthropol (1978) 0.93

Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (1999) 0.91

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial. Aliment Pharmacol Ther (2008) 0.91

Transcatheter embolization of the internal pudendal artery for control of massive perineal bleeding. Cardiovasc Intervent Radiol (1980) 0.91

Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity. Aliment Pharmacol Ther (2006) 0.90

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin. J Viral Hepat (2013) 0.90

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis. Aliment Pharmacol Ther (2008) 0.90

Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation. AJR Am J Roentgenol (1982) 0.90

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol (1990) 0.90

Emergency portacaval shunt for control of hemorrhage from a parenchymal fracture after adult-to-adult living donor liver transplantation. Transplantation (2000) 0.90

Sex discriminatory effectiveness using combinations of permanent teeth. J Dent Res (1977) 0.90

Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol (1997) 0.89

Computed tomographic detection of pelvic and inguinal lymph-node metastases from primary and recurrent pelvic malignant disease. Radiology (1980) 0.89

Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis. Ann Vasc Surg (1994) 0.89